165 related articles for article (PubMed ID: 25372834)
41. Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin.
Hu J; Renne R
J Virol; 2005 Feb; 79(4):2637-42. PubMed ID: 15681465
[TBL] [Abstract][Full Text] [Related]
42. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Garber AC; Shu MA; Hu J; Renne R
J Virol; 2001 Sep; 75(17):7882-92. PubMed ID: 11483733
[TBL] [Abstract][Full Text] [Related]
43. KSHV Genome Replication and Maintenance in Latency.
Ueda K
Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
[TBL] [Abstract][Full Text] [Related]
44. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.
Verma SC; Choudhuri T; Kaul R; Robertson ES
J Virol; 2006 Mar; 80(5):2243-56. PubMed ID: 16474132
[TBL] [Abstract][Full Text] [Related]
45. Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions.
Mattsson K; Kiss C; Platt GM; Simpson GR; Kashuba E; Klein G; Schulz TF; Szekely L
J Gen Virol; 2002 Jan; 83(Pt 1):179-188. PubMed ID: 11752715
[TBL] [Abstract][Full Text] [Related]
46. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
Skalsky RL; Hu J; Renne R
J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
[TBL] [Abstract][Full Text] [Related]
47. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA.
Wong LY; Wilson AC
J Virol; 2005 Nov; 79(21):13829-36. PubMed ID: 16227305
[TBL] [Abstract][Full Text] [Related]
48. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
[TBL] [Abstract][Full Text] [Related]
49. Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses.
Davis DA; Naiman NE; Wang V; Shrestha P; Haque M; Hu D; Anagho HA; Carey RF; Davidoff KS; Yarchoan R
PLoS Pathog; 2015 Jul; 11(7):e1005064. PubMed ID: 26218605
[TBL] [Abstract][Full Text] [Related]
50. Molecular basis for oligomeric-DNA binding and episome maintenance by KSHV LANA.
Domsic JF; Chen HS; Lu F; Marmorstein R; Lieberman PM
PLoS Pathog; 2013; 9(10):e1003672. PubMed ID: 24146617
[TBL] [Abstract][Full Text] [Related]
51. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.
Muromoto R; Okabe K; Fujimuro M; Sugiyama K; Yokosawa H; Seya T; Matsuda T
FEBS Lett; 2006 Jan; 580(1):93-8. PubMed ID: 16364321
[TBL] [Abstract][Full Text] [Related]
52. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
53. Kaposi's sarcoma-associated herpesvirus LANA recruits the DNA polymerase clamp loader to mediate efficient replication and virus persistence.
Sun Q; Tsurimoto T; Juillard F; Li L; Li S; De León Vázquez E; Chen S; Kaye K
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):11816-21. PubMed ID: 25071216
[TBL] [Abstract][Full Text] [Related]
54. Kaposi's sarcoma-associated herpesvirus-encoded LANA associates with glucocorticoid receptor and enhances its transcriptional activities.
Togi S; Nakasuji M; Muromoto R; Ikeda O; Okabe K; Kitai Y; Kon S; Oritani K; Matsuda T
Biochem Biophys Res Commun; 2015 Jul; 463(3):395-400. PubMed ID: 26032496
[TBL] [Abstract][Full Text] [Related]
55. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
[TBL] [Abstract][Full Text] [Related]
56. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin.
Stedman W; Deng Z; Lu F; Lieberman PM
J Virol; 2004 Nov; 78(22):12566-75. PubMed ID: 15507644
[TBL] [Abstract][Full Text] [Related]
57. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
Kedes DH; Lagunoff M; Renne R; Ganem D
J Clin Invest; 1997 Nov; 100(10):2606-10. PubMed ID: 9366576
[TBL] [Abstract][Full Text] [Related]
58. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
59. Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence.
Kelley-Clarke B; De Leon-Vazquez E; Slain K; Barbera AJ; Kaye KM
J Virol; 2009 May; 83(9):4326-37. PubMed ID: 19225000
[TBL] [Abstract][Full Text] [Related]
60. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency.
De Leo A; Deng Z; Vladimirova O; Chen HS; Dheekollu J; Calderon A; Myers KA; Hayden J; Keeney F; Kaufer BB; Yuan Y; Robertson E; Lieberman PM
PLoS Pathog; 2019 Jan; 15(1):e1007489. PubMed ID: 30682185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
